Publication | Closed Access

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia

Hematological MalignancyDouble Induction StrategyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyPharmacologyHigh Dose CytarabinePharmacotherapyAdult T-cell Leukemia-lymphomaOncologyAll-trans Retinoic AcidCancer ResearchMyeloid Neoplasia